GoodRx published a list of the 20 most expensive drugs in the U.S. Aug. 11, including only medications filled at pharmacies that patients can self-administer on a regular basis. It posted another ranking of the 10 most expensive drugs in the country Aug. 25, including both drugs dispensed at pharmacies and those that must be administered by a healthcare provider.
The 10 most expensive drugs in the U.S. based on their annual list prices:
- Zolgensma — $2,125,000 (AveXis)
- Myalept — $855,678 (Amryt Pharma)
- Luxturna — $850,000 (Spark Therapeutics)
- Folotyn — $793,870 (Acrotech Biopharma)
- Brineura — $716,040 (BioMarin Pharmaceuticals)
- Soliris — $678,392 (Alexion Pharmaceuticals)
- Blincyto — $672,968 (Amgen)
- Ravicti — $664,092 (Horizon Therapeutics)
- Lumizyme — $643,243 (Sanofi Genzyme)
- Actimmune — $633,325 (Horizon Therapeutics)
More articles on pharmacy:
Biogen conference may have led to 20,000 COVID-19 infections, researchers say
AbbVie, Harvard partner to study coronavirus therapies
Patients over 50 may take meds less if pill appearance changes a lot, study says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
